| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/16/2011 | WO2011004398A4 Preservatives from chitin derivatives |
| 06/16/2011 | WO2010139942A3 Nanoparticle for biomolecule delivery |
| 06/16/2011 | WO2010125470A3 Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| 06/16/2011 | WO2010122490A3 A medicinal anti diaper rash cream incorporating a biopolymer and a process to make it |
| 06/16/2011 | WO2010089617A3 Transdermal pharmaceutical preparations |
| 06/16/2011 | WO2009132234A3 Medical devices, polymers, compositions, and methods for delivering a haloacetate |
| 06/16/2011 | US20110144577 Hydrophilic coatings with tunable composition for drug coated balloon |
| 06/16/2011 | US20110144218 Taste-Modified Consumable Products And Methods Of Preparation |
| 06/16/2011 | US20110144147 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| 06/16/2011 | US20110144054 Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents |
| 06/16/2011 | US20110144042 Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative |
| 06/16/2011 | US20110144035 Methods and Compositions for Treating Conditions of the Eye |
| 06/16/2011 | US20110144008 Peptide agonists of glp-1 activity |
| 06/16/2011 | US20110143995 Novel anti-allergic agents |
| 06/16/2011 | US20110143991 Peptides for Activation and Inhibition of Delta-PKC |
| 06/16/2011 | US20110143944 Linear cyclodextrin copolymers |
| 06/16/2011 | US20110142925 Film Coating For Tablets And Caplets |
| 06/16/2011 | US20110142896 Water-dispersible and multicomponent fibers from sulfopolyesters |
| 06/16/2011 | US20110142888 Film coating compositions based on polyvinyl alcohol-polyether graft copolymer/polyvinyl alcohol combinations with an improved moisture barrier effect |
| 06/16/2011 | US20110142847 Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 |
| 06/16/2011 | US20110142787 Polymerized cyclic nitroxide radical compound and use thereof |
| 06/16/2011 | US20110139669 Preparing of products, in particular cellulose-containing products and/or spaces |
| 06/16/2011 | CA2821513A1 Glycerine based jelly compositions |
| 06/16/2011 | CA2784005A1 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt) |
| 06/16/2011 | CA2783877A1 Ph sensitive compounds in taste masking within oral thin film strips |
| 06/16/2011 | CA2783707A1 Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
| 06/16/2011 | CA2783535A1 Stable formulations for lyophilizing therapeutic particles |
| 06/16/2011 | CA2783342A1 Gastric retentive pharmaceutical compositions for extended release of polypeptides |
| 06/16/2011 | CA2782838A1 Bche albumin fusions for the treatment of cocaine abuse |
| 06/16/2011 | CA2782779A1 Mucoadhesive buccal tablets for the treatment of orofacial herpes |
| 06/16/2011 | CA2782015A1 Compositions and methods for the treatment of macular degeneration |
| 06/16/2011 | CA2781717A1 Dock-and-lock (dnl) complexes for delivery of interference rna |
| 06/15/2011 | EP2332970A2 Mutated pseudomonas exotoxins with reduced antigenicity |
| 06/15/2011 | EP2332966A1 Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer |
| 06/15/2011 | EP2332581A1 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
| 06/15/2011 | EP2332574A1 HCV NS3/4A Sequences |
| 06/15/2011 | EP2332564A1 Matrix-free osteogenic devices, implants and methods thereof |
| 06/15/2011 | EP2332553A1 Methods and compositions to treat myocardial conditions |
| 06/15/2011 | EP2332535A1 Solid pharmaceutical composition |
| 06/15/2011 | EP2332531A1 Apo2 ligand/TRAIL formulations |
| 06/15/2011 | EP2332523A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 06/15/2011 | EP2332425A1 Flavor improving agent |
| 06/15/2011 | EP2332414A2 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 06/15/2011 | EP2331629A1 Starch-based microparticles for the release of agents disposed therein |
| 06/15/2011 | EP2331140A1 Multi-arm polymeric alkanoate conjugates |
| 06/15/2011 | EP2331139A2 Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method |
| 06/15/2011 | EP2331138A1 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
| 06/15/2011 | EP2331129A1 Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| 06/15/2011 | EP2331090A1 Stable liquid antibody formulation |
| 06/15/2011 | EP2331078A1 Lyophilized formulatons of engineered anti-il-23p19 antibodies |
| 06/15/2011 | EP2331073A1 New controlled release active agent carrier |
| 06/15/2011 | EP2331071A1 Novel multimodular assembly useful for intracellular delivery |
| 06/15/2011 | EP2331070A1 Method of solubilising biologically active compounds |
| 06/15/2011 | EP2331069A1 Heterogeneous polymeric micelles for intracellular delivery |
| 06/15/2011 | EP2331066A1 Mucomimetic compositions and uses therefore |
| 06/15/2011 | EP2234492B1 Pharmaceutical composition containing an n-phenylpyrazole derivative and glycofurol, use for the preparation of a topical veterinary medicament for combating fleas |
| 06/15/2011 | EP2162154B1 Colored esmolol concentrate |
| 06/15/2011 | EP2117514B1 Compositions comprising peg- interferon alpha conjugates and raffinose as cryoprotectant |
| 06/15/2011 | EP1827413B1 Use of cyclodextrin complexes containing lipoic acid |
| 06/15/2011 | EP1740217B1 Meningococcal conjugate vaccination |
| 06/15/2011 | EP1583562B1 Angiopep-1, related compounds, and uses thereof |
| 06/15/2011 | EP1455596B9 Capsule with fast content solubilization and release |
| 06/15/2011 | EP1417229B1 Methods and compounds for the targeting of protein to exosomes |
| 06/15/2011 | EP1407267B1 Gel compositions |
| 06/15/2011 | CN201861993U Carrier for spreading black plaster |
| 06/15/2011 | CN1985842B Oral azithromycin resin suspension and its preparing method |
| 06/15/2011 | CN1969874B Externally applied pharmaceutical composition of abafungin |
| 06/15/2011 | CN1954883B Method for stabilizing hemoglobin oxygen carrier sample |
| 06/15/2011 | CN1452636B Human monoclonal antibodies to dendritis cells |
| 06/15/2011 | CN102099684A Kit for detecting cancer cells metastasizing into sentinel lymph node |
| 06/15/2011 | CN102099408A Polymer microgel beads and preparative method thereof |
| 06/15/2011 | CN102099407A Polymer microgel beads |
| 06/15/2011 | CN102099058A Novel reagents and method for conjugating biological molecules |
| 06/15/2011 | CN102099057A A conjugate of an antibody against CD4 and antifusogenic peptides |
| 06/15/2011 | CN102099056A A pharmaceutical composition |
| 06/15/2011 | CN102099047A Composition for controlling increase in blood glucose |
| 06/15/2011 | CN102099037A Stable aqueous solution composition containing sulfonamide compound |
| 06/15/2011 | CN102099022A Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid |
| 06/15/2011 | CN102099020A Stabilized transdermal drug delivery system |
| 06/15/2011 | CN102099016A Drug loaded polymeric nanoparticles and methods of making and using same |
| 06/15/2011 | CN102099015A Articles of manufacture releasing an active ingredient |
| 06/15/2011 | CN102099012A Method for manufacturing medicinal compounds containing dabigatran |
| 06/15/2011 | CN102093831A Hot-melt pressure-sensitive adhesive and preparation method and application thereof |
| 06/15/2011 | CN102093578A Preparation method of shape-controllable amino-acid ester (with side group benzene ring) substituted polyphosphazene microspheres |
| 06/15/2011 | CN102093555A Polymer nano hydrogel and preparation method thereof |
| 06/15/2011 | CN102093546A Method for synthesizing polylactic acid by using catalytic one-step method and taking calcined kaoline as catalyst |
| 06/15/2011 | CN102093489A Amphiphilic N-long chain alkyl-N-arginine chitosan derivative and preparation of derivative micelle |
| 06/15/2011 | CN102093487A Method for extracting pectin from akebia trifoliata var australis peel |
| 06/15/2011 | CN102093480A Recombinant human serum albumin-interferon alpha 1b fusion protein and preparation method thereof |
| 06/15/2011 | CN102093446A Doxorubicin liposome derivatives and preparation method thereof |
| 06/15/2011 | CN102093403A Azobenzene group-containing complex lipid and intermediate, preparation method and application thereof |
| 06/15/2011 | CN102093234A Tromethamine salt compound of dibasic ester acid, preparation method and medicinal application thereof |
| 06/15/2011 | CN102091334A Method for preparing adenovirus-chitosan nano composite material |
| 06/15/2011 | CN102091332A Self-assembly system based on hydrophilic polymer and medicine and preparation method thereof |
| 06/15/2011 | CN102091331A Carboxyl mesoporous silica nanoparticle carrier material and preparation method thereof |
| 06/15/2011 | CN102091326A Transdermal medicament delivery preparation for treating hemorrhoid diseases caused by expansion or varix of anal subcutaneous veniplex and preparation method thereof |
| 06/15/2011 | CN102091284A Xingnaojing oral emulsion for treating cerebral apoplexy and preparation method thereof |
| 06/15/2011 | CN102091272A Black plaster product for bone fracture and preparation method thereof |
| 06/15/2011 | CN102091219A New Huang's sound pills and preparation method thereof |
| 06/15/2011 | CN102091201A Medicament for treating irradiation-induced skin reaction and preparation method thereof |